A long-term, safety extension study of AVONEX® (Interferon beta-1a) involving patients with relapsing multiple sclerosis.
Terms and Conditions of Use // Copyright © BIOGEN. Designed by Foster Design Group, Inc., and created and maintained by embarc. // Note Regarding Forward Looking Statements // Privacy Policy
